LLY
Eli Lilly
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Signals Analysis
Buy signal 4
Sell signal 1
consensus rating "Buy"
EPS Beats Expectation
Price Hits New High
Low Beta
Revenue Below Expectations
Key Stats
--DAY`S RANGE--
--52 WK RANGE--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
About LLY
Eli Lilly And Company
A global pharmaceutical leader with a diverse portfolio of innovative medicines and treatments for various diseases and conditions
Lilly Corporate Center, Indianapolis, Indiana 46285
Drug production and sales
Incorporated in Indiana in 1901, Eli Lilly was formerly a pharmaceutical manufacturer founded in 1876 by Colonel Eli Lilly in Indianapolis, Indiana. The company discovers, develops, manufactures and sells important pharmaceutical products. The company's mission is to combine "caring" with "discovery" to create a better life for people around the world.
Company Financials
EPS
LLY has released its 2024 Q4 earnings. EPS was reported at 5.32, versus the expected 5.08, beating expectations. The chart below visualizes how LLY has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
LLY has released its 2024 Q4 earnings report, with revenue of 13.53B, reflecting a YoY change of 44.68%, and net profit of 4.41B, showing a YoY change of 101.40%. The Sankey diagram below clearly presents LLY’s revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
